Groups | Total proteins | ALT | AST |
---|
Concentration (mg/mL) | % change | Activity (UI/L) | % change | Activity (UI/L) | % change |
---|
UIC | 0.91 ± 0.03 | | 116.33 ± 14.28 | | 113.59 ± 9.29 | |
IC | 0.79 ± 0.02* | - 13.19 | 842.60 ± 91.12*** | + 624.32 | 267.81 ± 16.34*** | + 135.77 |
PZQ | 0.77 ± 0.03* | / | 171.64 ± 15.69### | - 79.63 | 179.78 ± 10.58**, ### | - 32.87 |
SpAE 200 | 0.90 ± 0.03#, £ | + 13.92 | 159.29 ± 16.13### | - 81.09 | 136.76 ± 9.78###, £ | - 48.93 |
- UIC Uninfected-untreated mice, IC Infected-untreated mice, PZQ Infected mice treated with praziquantel, SpAE 200 Infected mice treated with Sida pilosa aqueous extract at 200 mg/kg
- Data are expressed as mean ± SEM (n = 6). ANOVA followed by Newman-Keuls multiple comparison test was used for statistical analysis. *p < 0.05, **p < 0.01, ***p < 0.001: values are significantly different from those of uninfected-untreated mice (group UIC). #p < 0.05, ###p < 0.001: values are significantly different from those of infected-untreated mice (group IC). £p < 0.05: values are significantly different from those of infected mice treated with praziquantel (group PZQ)